Prevalence of gastrointestinal disorders having an impact on tablet levothyroxine absorption: should this formulation still be considered as the first-line therapy?

Venerdì 17 gennaio 2020 circa 1 minuti di lettura

Journal and Affiliations:
Endocrine, 17 gennaio 2020

Luca Giovanella, Ente Ospedaliero Cantonale, Bellinzona

Pierpaolo Trimboli, Ente Ospedaliero Cantonale, Bellinzona + USI, Lugano

Tags: [none]
Authors:
Luca Giovanella
Pierpaolo Trimboli
Link: Prevalence of gastrointestinal disorders having an impact on tablet levothyroxine absorption: should this formulation still be considered as the first-line therapy?